GHR Rechtsanwälte has advised Gfeller Elektro on the sale of the100% of the company’s shares for an undisclosed price to VINCI Energies, a member of the VINCI Group. VINCI Energies posted revenue of €716.6
Tags :Slider
VASS, an European IT consulting company focusing on digitalization has acquired the Swiss One Inside. Vass, which is headquartered in Spain, is currently present in 25 countries worldwide. The Swiss company One Inside is an IT
Niederer Kraft Frey, a Zuric-based law firm, joins forces with Geneva firm Tavernier Tschanz and a team from Python. From 2023, they will form in Zurich and Geneva one of the most important national law firms.
MLL acted as lead counsel to Crest Rock Partners, a Denver-based private equity fund, on a transaction that led to a strategic growth investment in Pitcher. The Zurich based company is a provider of sales
The French Group ONET announces the takeover of all its commercial activities in Facility Management in Switzerland by Honegger. The ONET Group has taken this decision after more than 50 years of presence in Switzerland. The
Foxstone has completed a CHF 10 million Series A financing round. The online platform is a fast growing real estate crowdfunding that democratizes real investment through technology and has attracted new investors including the Swiss family
UBS Switzerland has participated as well as other Banks together with Nova Property Fund Management on the refinancing and further supporting development of the Klybeckareal Project in Basel city. UBS has acted as mandated lead
Vantage Education Group, one of the leading providers of education and training in Switzerland, has completed an extensive refinancing, with UBS Switzerland acting as mandated lead arranger, agent, security agent and original lender, and Berner
Julius Baer Group has placed a perpetual non-cumulative Additional Tier 1 (AT1) securities in a USD 400 million transaction with private banks and institutional investors in Asia and Europe. The transaction will help to optimise Julius Baer
The Swiss pharmaceutical BioVersys has raised CHF 24.2 million in a first closing of its Series C round. This first closing was significantly oversubscribed by both existing and new investors from diverse geographies. The company intends
